New Genetic Tool Assesses Cardiovascular Risk
New genetic tool assesses inherited risk for 8 cardiovascular conditions. Identifies high-risk individuals but needs diverse population validation.
New genetic tool assesses inherited risk for 8 cardiovascular conditions. Identifies high-risk individuals but needs diverse population validation.
Apolipoprotein B (apoB) testing is a more effective, cost-efficient way to guide cholesterol treatment and prevent cardiovascular events than current methods.
Daily low-dose aspirin shows limited and uncertain benefits for colorectal cancer prevention, while increasing the risk of serious bleeding events.
Vitamin D may cut type 2 diabetes risk by 19% in prediabetics with specific genes, highlighting precision medicine's potential.
Changes in the gut microbiome may serve as an early indicator for Parkinson's disease, potentially enabling earlier detection and intervention strategies.
Natural GLP-1 hormone has been detected in joint fluid, indicating a potential direct therapeutic pathway for GLP-1-based drugs in arthritis treatment.
A study found that anemia is associated with a 66% increased risk of dementia, particularly in men, and is linked to higher Alzheimer's disease biomarkers.